Garand M, Huang S, Goessling L, Santillan D, Santillan M, Brar A
Microorganisms. 2022; 10(10).
PMID: 36296201
PMC: 9610878.
DOI: 10.3390/microorganisms10101925.
Wan Z, Liu J, Hu F, Shui J, Li L, Wang H
Emerg Microbes Infect. 2020; 9(1):485-495.
PMID: 32100631
PMC: 7054972.
DOI: 10.1080/22221751.2020.1730247.
Wang C, Timmons C, Shao Q, Kinlock B, Turner T, Iwamoto A
Oncotarget. 2015; 6(41):43293-309.
PMID: 26675377
PMC: 4791233.
DOI: 10.18632/oncotarget.6537.
Liu Z, Zhang Y, Wei F, Xu M, Mou D, Zhang T
Epidemiol Infect. 2015; 144(1):106-12.
PMID: 26081197
PMC: 9507311.
DOI: 10.1017/S0950268815001326.
Lanteri M, Vahidnia F, Tan S, Stapleton J, Norris P, Heitman J
J Infect Dis. 2014; 211(10):1585-96.
PMID: 25425697
PMC: 4481614.
DOI: 10.1093/infdis/jiu660.
A novel T cell evasion mechanism in persistent RNA virus infection.
Stapleton J, Xiang J, McLinden J, Bhattarai N, Chivero E, Klinzman D
Trans Am Clin Climatol Assoc. 2014; 125:14-24.
PMID: 25125715
PMC: 4112695.
Deep sequencing identifies two genotypes and high viral genetic diversity of human pegivirus (GB virus C) in rural Ugandan patients.
Ghai R, Sibley S, Lauck M, Dinis J, Bailey A, Chapman C
J Gen Virol. 2013; 94(Pt 12):2670-2678.
PMID: 24077364
PMC: 3836497.
DOI: 10.1099/vir.0.055509-0.
A strategy to estimate unknown viral diversity in mammals.
Anthony S, Epstein J, A Murray K, Navarrete-Macias I, Zambrana-Torrelio C, Solovyov A
mBio. 2013; 4(5):e00598-13.
PMID: 24003179
PMC: 3760253.
DOI: 10.1128/mBio.00598-13.
GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways.
Bhattarai N, McLinden J, Xiang J, Kaufman T, Stapleton J
J Immunol. 2012; 189(5):2211-6.
PMID: 22844114
PMC: 3424397.
DOI: 10.4049/jimmunol.1201324.
GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression.
Rydze R, Xiang J, McLinden J, Stapleton J
J Infect Dis. 2012; 206(1):69-72.
PMID: 22535999
PMC: 3415935.
DOI: 10.1093/infdis/jis312.
Transmission of GB virus type C via transfusion in a cohort of HIV-infected patients.
Vahidnia F, Petersen M, Rutherford G, Busch M, Assmann S, Stapleton J
J Infect Dis. 2012; 205(9):1436-42.
PMID: 22438325
PMC: 3324396.
DOI: 10.1093/infdis/jis209.
Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.
Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H
J Virol. 2011; 85(14):7037-47.
PMID: 21543477
PMC: 3126597.
DOI: 10.1128/JVI.02366-10.
The natural history of non-human GB virus C in captive chimpanzees.
Mohr E, Murthy K, McLinden J, Xiang J, Stapleton J
J Gen Virol. 2010; 92(Pt 1):91-100.
PMID: 20861317
PMC: 3052534.
DOI: 10.1099/vir.0.026088-0.
GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates.
Mohr E, Xiang J, McLinden J, Kaufman T, Chang Q, Montefiori D
J Immunol. 2010; 185(7):4496-505.
PMID: 20826757
PMC: 3544363.
DOI: 10.4049/jimmunol.1001980.
GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.
Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard J
Antivir Ther. 2010; 15(5):745-52.
PMID: 20710056
PMC: 3210471.
DOI: 10.3851/IMP1602.
The evolution of HIV-1 and the origin of AIDS.
Sharp P, Hahn B
Philos Trans R Soc Lond B Biol Sci. 2010; 365(1552):2487-94.
PMID: 20643738
PMC: 2935100.
DOI: 10.1098/rstb.2010.0031.
GB virus type C interactions with HIV: the role of envelope glycoproteins.
Mohr E, Stapleton J
J Viral Hepat. 2009; 16(11):757-68.
PMID: 19758271
PMC: 3543829.
DOI: 10.1111/j.1365-2893.2009.01194.x.
Hepatitis G virus.
Reshetnyak V, Karlovich T, Ilchenko L
World J Gastroenterol. 2008; 14(30):4725-34.
PMID: 18720531
PMC: 2739332.
DOI: 10.3748/wjg.14.4725.
Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication.
Xiang J, McLinden J, Chang Q, Jordan E, Stapleton J
PLoS One. 2008; 3(7):e2580.
PMID: 18596910
PMC: 2440355.
DOI: 10.1371/journal.pone.0002580.
Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding.
McLinden J, Kaufman T, Xiang J, Chang Q, Klinzman D, Engel A
J Virol. 2006; 80(24):12131-40.
PMID: 17035329
PMC: 1676310.
DOI: 10.1128/JVI.01206-06.